Efficacy of Duloxetine and Selective Serotonin Reuptake Inhibitors
Michael E. Thase(Veterans Health Administration), Michael J. Detke(Eli Lilly (United States)), Yili Pritchett(Abbott (United Kingdom)), Melissa J. Ossanna(Eli Lilly (United States)), Ralph Swindle(Eli Lilly (United States)), Jimmy Yu Xu(Eli Lilly (United States))
Cited by 113
Related Papers
The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
|Biological Psychiatry|2003|3.9k
A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression
|New England Journal of Medicine|2000|1.3k
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design
|Controlled Clinical Trials|2004|1.1k
Frontiers of cognitive therapy
|General Hospital Psychiatry|1997|1.1k